ABSTRACr Non-specific bronchial reactivity was assessed in 17 consecutive non-smoking and non-steroid treated patients with recently diagnosed pulmonary sarcoidosis, 11 one had had asthma for eight years as a child; one had current asthma and one rhinitis, conjunctivitis, and asthma. These three patients were excluded from our evaluation.
Inflammatory reactions in the bronchial mucosa may increase airway reactivity to irritant agents-for example, in patients with farmer's lung.' 2 In early sarcoidosis gallium scintigrams and bronchoalveolar lavage indicate an alveolitis with activated macrophages and T lymphocytes,3 and this could cause inflammatory reactions in the lower airways and thereby an increase in airway reactivity. Many patients with pulmonary sarcoidosis have airways obstruction due to granulomatous infiltrates in the bronchial mucosa, while others show reversible airways obstruction.4 5 A transient increase in nonspecific bronchial reactivity in sarcoidosis was thought to be due to changes in the airway epithelium.6 To assess whether non-smokers with early non-treated sarcoidosis have hyperreactive airways, we studied airway reactivity in 17 consecutive patients referred to the department of lung medicine of the University of Lund.
Methods
We studied 10 women and seven men admitted consecutively with recently diagnosed sarcoidosis. They had a mean age of 32 (range 22-48) years and an average height of 172 (153-184) cm and weight of 64 (49-86) kg. Fourteen had no history of asthma; one had had asthma for eight years as a child; one had current asthma and one rhinitis, conjunctivitis, and asthma. These three patients were excluded from our evaluation.
The table shows data from the 14 patients studied, of whom nine had a history of acute sarcoidosis. Ten had a chest radiograph compatible with stage I disease and four with stage II. Epitheloid cell granulomas were found in nine of the 10 subjects who had a biopsy. The Mantoux reaction of 2 tuberculin units PPD was negative in nine subjects, and 10 and 11 mm in the other two in whom it was measured. The mean time from the start of symptoms or from a positive radiograph to the study of bronchial reactivity was 4-7 (range 2-10) months.
Five patients had a family history of asthma and atopic diseases but the total IgE concentration (< 15 kU/1) or blood eosinophil count (0-1-0-26 x 109/l) (or both) was within normal limits in all cases.
Mean FEV, and FVC as percentage of predicted were 96% (range 79-123%) and 93% (range 78-112%) (table) . A methacholine provocation test was performed by a standardised method and used to construct a methacholine dose -FEV, response curve. 8 The results from a previous study of normal subjects using the same technique were used for comparison with the results from the present subjects. We 
Discussion
Our aim was to assess whether the recent onset of pulmonary sarcoidosis increased airway reactivity. We excluded factors known to affect the responsiveness of the airways, such as smoking and steroid treatment. Among the first 10 consecutive patients we unexpectedly found four hyperreactive patients. Three of these had a history of asthma, which may be unconnected with the sarcoidosis. After exclusion of these three subjects the remaining subjects had normal spirometric values.
We have found only two previous publications on airway reactivity in sarcoidosis. Bechtel et al report increased airway reactivity in 20 patients with pulmonary sarcoidosis compared with 13 normal controls.9 Their hyperreactive patients with sarcoidosis tended to have more airways obstruction, a lower vital capacity, and more symptoms of wheezing and cough than the normal subjects, although the differences were not significant. The subjects included smokers and non-smokers, patients treated with corticosteroids, and patients who had-been ill for up to 12x5 years. In another study Magalif 
